[Serum levels of IAP, CEA and CA19-9 in patients with urological malignancies].
Iizumi
T
T
Amemiya
H
H
Hata
R
R
Kaneko
S
S
Muramatsu
H
H
Kariba
T
T
Toyoshima
A
A
Yazaki
T
T
Waku
M
M
D000368:Aged; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis*; D009367:Neoplasm Staging; D011379:Prognosis; D014571:Urologic Neoplasms / Q000175:diagnosis* / Q000473:pathology
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D009363:Neoplasm Proteins; C030193:immunosuppressive acidic protein